Please enable JavaScript or talk to your local administrator to get JavaScript enabled.


Refined phenotyping and personalized targeting of muscle-invasive bladder cancer

Funder: Swiss National Science Foundation

Funding period
CHF 692 K
USD 703 K
Funding amount
Bladder cancer is a lethal disease and half of patients with MIBC will succumb to their disease despite optimal therapy. Molecular subtypes of MIBC provides a framework for the understanding of the biology of this disease and these subtypes show differences in response to systemic treatments (e.g. to cisplatin or novel targeted therapies). We discovered genomic test, that determines the molecular subtype in a single patient tumor. This allows us to select tumors with a specific molecular subtype for further investigation. In this proposal, we aim to characterize patient derived models for the investigation of tumors of specific molecular subtypes. Furthermore, we will determine whether the investigation of the genomic landscape of bladder cancer specimens allow to predict treatment response. This proposal will serve as proof of concept, that molecular profiles allow to determine the molecular phenotype of the subsequent patient derived models and to predict their responsiveness in a personalized manner.
Similar projects All >
Sorted by: Start Date
Project list item
Developing a SMART scaffold for bladder augmentation

National Institute of Biomedical Imaging and Bioengineering to GUILLERMO ANTONIO AMEER, JOHN ROGERS, ARUN SHARMA

USD 709,004
2019 - 2023
Project list item
Investigating underlying molecular mechanisms of epigenetic therapies in muscle-invasive bladder cancer

Bladder Cancer Advocacy Network to Swathi Ramakrishnan

USD 1,700
2019 - 2019
Project list item
Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer

Bladder Cancer Advocacy Network to Philip A Beachy, Kris Butalid Prado

USD 300,000
2019 - 2021
Project list item
Recombinant CCL2 as a novel treatment strategy for bladder cancer

Bladder Cancer Advocacy Network to Neelam Mukherjee, Robert Scott Svatek

USD 50,000
2019 - 2020



    1112 Oncology and Carcinogenesis

  • RCDC


  • RCDC

    Human Genome

  • RCDC


  • RCDC

    Clinical Research

  • RCDC


  • RCDC

    Urologic Diseases




    2.1 Biological and endogenous factors

  • Health Research Areas


  • Broad Research Areas

    Clinical Medicine and Science